CLINICAL_TRIALS
trial_result
· 2011-06-07
Clinical Trial Update: Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial results compare linagliptin added to metformin versus placebo in adults with type 2 diabetes, assessing efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2011-06-07